XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative effect adjustment
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Loss
Retained Earnings
Retained Earnings
Cumulative effect adjustment
Beginning balance (in shares) at Jun. 28, 2020     145,331          
Beginning balance at Jun. 28, 2020 $ 5,172,494 $ 1,157 $ 145 $ 6,695,858 $ (12,949,889) $ (94,211) $ 11,520,591 $ 1,157
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock (in shares)     205          
Issuance of common stock 13,646     13,646        
Purchase of treasury stock (in shares)     (3,156)          
Purchase of treasury stock (1,194,842)   $ (3)   (1,194,839)      
Reissuance of treasury stock (in shares)     207          
Reissuance of treasury stock 41,434     32,261 9,173      
Equity-based compensation expense 108,097     108,097        
Effect of conversion of convertible notes (in shares)     618          
Effect of conversion of convertible notes (660)   $ 1 (661)        
Reclassification from temporary to permanent equity 5,480     5,480        
Net income 1,692,680           1,692,680  
Other comprehensive income (loss) 38,085         38,085    
Cash dividends declared (374,538)           (374,538)  
Ending balance (in shares) at Dec. 27, 2020     143,205          
Ending balance at Dec. 27, 2020 5,503,033   $ 143 6,854,681 (14,135,555) (56,126) 12,839,890  
Beginning balance (in shares) at Sep. 27, 2020     144,593          
Beginning balance at Sep. 27, 2020 5,419,185   $ 145 6,761,545 (13,416,986) (82,672) 12,157,153  
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock (in shares)     100          
Issuance of common stock 8,108     8,108        
Purchase of treasury stock (in shares)     (1,796)          
Purchase of treasury stock (727,744)   $ (2)   (727,742)      
Reissuance of treasury stock (in shares)     207          
Reissuance of treasury stock 41,434     32,261 9,173      
Equity-based compensation expense 52,109     52,109        
Effect of conversion of convertible notes (in shares)     101          
Effect of conversion of convertible notes (134)     (134)        
Reclassification from temporary to permanent equity 792     792        
Net income 869,229           869,229  
Other comprehensive income (loss) 26,546         26,546    
Cash dividends declared (186,492)           (186,492)  
Ending balance (in shares) at Dec. 27, 2020     143,205          
Ending balance at Dec. 27, 2020 5,503,033   $ 143 6,854,681 (14,135,555) (56,126) 12,839,890  
Beginning balance (in shares) at Jun. 27, 2021     142,501          
Beginning balance at Jun. 27, 2021 6,027,188 [1]   $ 143 7,052,962 (15,646,701) (64,128) 14,684,912  
Ending balance (in shares) at Sep. 26, 2021     140,811          
Ending balance at Sep. 26, 2021 5,820,043   $ 141 7,111,803 (16,863,573) (81,768) 15,653,440  
Beginning balance (in shares) at Jun. 27, 2021     142,501          
Beginning balance at Jun. 27, 2021 6,027,188 [1]   $ 143 7,052,962 (15,646,701) (64,128) 14,684,912  
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock (in shares)     99          
Issuance of common stock 4,193   $ 0 4,193        
Purchase of treasury stock (in shares)     (2,422)          
Purchase of treasury stock (1,651,666)   $ (3)   (1,651,663)      
Reissuance of treasury stock (in shares)     97          
Reissuance of treasury stock 46,380     42,271 4,109      
Equity-based compensation expense 120,933     120,933        
Net income 2,374,574           2,374,574  
Other comprehensive income (loss) (24,018)         (24,018)    
Cash dividends declared (421,803)           (421,803)  
Ending balance (in shares) at Dec. 26, 2021     140,275          
Ending balance at Dec. 26, 2021 6,475,781   $ 140 7,220,359 (17,294,255) (88,146) 16,637,683  
Beginning balance (in shares) at Sep. 26, 2021     140,811          
Beginning balance at Sep. 26, 2021 5,820,043   $ 141 7,111,803 (16,863,573) (81,768) 15,653,440  
Increase (Decrease) in Stockholders' Equity                
Issuance of common stock (in shares)     52          
Issuance of common stock 3,451   $ 0 3,451        
Purchase of treasury stock (in shares)     (685)          
Purchase of treasury stock (434,792)   $ (1)   (434,791)      
Reissuance of treasury stock (in shares)     97          
Reissuance of treasury stock 46,380     42,271 4,109      
Equity-based compensation expense 62,834     62,834        
Net income 1,194,830           1,194,830  
Other comprehensive income (loss) (6,378)         (6,378)    
Cash dividends declared (210,587)           (210,587)  
Ending balance (in shares) at Dec. 26, 2021     140,275          
Ending balance at Dec. 26, 2021 $ 6,475,781   $ 140 $ 7,220,359 $ (17,294,255) $ (88,146) $ 16,637,683  
[1] Derived from audited financial statements